… the treatment of bacterial infections. Although the original ,B-lactamase described was primarily
… by chloride isa distinguishing characteristic of the oxacillin-hydrolyzing ,B-lactamases. p-…

… of infections caused by extended-spectrum betalactamase- (… factors associated with these
infections in a neonatal intensive … ESBL infection incidence densities were found to be 3.4 per …

… observational character of … iv) Beta-lactamase characterization. Isoelectric focusing (IEF)
and PCR were used for preliminary characterization of the beta-lactamases and beta-lactamase …

… This study was undertaken to characterize infections caused by ESBL-producing E. coli,
collected in the Cape Town metropolitan area, and to investigate the occurrence of clone ST131 …

… whether a carbapenem must be used to treat serious infections caused by ESBLs or whether
some of the older β-lactam-β-lactamase combinations such as piperacillin/tazobactam are …

… Although in vitro tests of ESBLs are inhibited by betalactamase inhibitors … beta-lactams
and beta-lactamase inhibitors appear to represent an important alternative for treating infections …

… various types of infections and have not clearly demonstrated that therapy with β-lactams is
… describe the clinical and microbiological characteristics of bloodstream infections (BSIs) due …

… delineate clinical characteristics of urosepsis caused by extended-spectrum beta-lactamase-…
(ESBL-EK) in different clinical settings, with an emphasis on community-acquired infections. …

… However, characteristics of infection caused by ESBL-producing P. mirabilis … infections:
risk factors and treatment outcome related to the expression of extended-spectrum b-lactamases. …

… may be available to treat infections caused by these microorganisms. As the ESBL resistance
mechanism is commonly expressed by plasmid encoded B lactamases, resistance can be …